Happy holidays!

With today's issue, we're concluding another year's coverage of the pharma industry. FiercePharma and its sister publications will be taking a publishing holiday until January 5th, when we'll be back with our annual forecast for the industry, including a look at FiercePharma's most popular stories of 2008. Enjoy the holidays and look for us in the New Year! - Maureen

Suggested Articles

Hengrui's Sun Piaoyang is stepping down as chairman, but he'll retain control of the pharma major he's headed for 30 years—and made a fortune…

Astellas tapped Adaptimmune to develop T-cell therapies. Ireland hit Takeda with an unexpected Shire tax bill. PD-1 med Tyvyt hit its goal in NSCLC.

AbbVie and Allergan's merger may create the fourth-largest drugmaker in the world, but it could also create opportunities for other drugmakers.